Ravi Nalliah, CEO at TrakCel talks about the new era of "personalized logistics" in this article in BioPharma Reporter.
Note: see our April Blog entry about our collaboration with TrakCel here
Dude where’s my CAR-T? Personalised meds need personalised logistics, says TrakCel
By Dan Stanton+, 01-Sep-2017
After receiving approval Kymriah, Novartis must prove it can handle the supply chain complexities of manufacturing high-value and time-sensitive CAR-T cell therapies, says logistics firm TrakCel.